08.09.2016 • NewsElaine BurridgeSABICPlastics and Polymers

SABIC Sells Polymershapes to Blackfriars

(c) Srebrina Yaneva
(c) Srebrina Yaneva

SABIC has sold its Polymershapes business to US investment firm Blackfriars Corp. for an undisclosed price. Polymershapes is a major distributor of plastic sheet, rod, tube and film, serving more than 35,000 customers through its network of over 75 locations in the US, Canada, Mexico and Chile.

The Saudi Arabian chemical giant said that while Polymershapes had been a profitable business, it no longer fitted in with its future plans. “As part of our ongoing effort to actively manage our portfolio, we concluded that this business no complements our core strategy,” said SABIC vice chairman and CEO Yousef Al-Benyan. 

SABIC said the sale would not affect its distribution activities or have a substantial impact on its finances. Al-Benyan said the group would direct resources more intently on providing specialty resins and chemicals and/or their formulations or forms, as well as studying potential growth opportunities. The transaction is expected to complete during the fourth quarter of 2016.

Blackfriars, based in Northbrook, Illinois, also owns Laird Plastics, a major plastics distributor located in Boca Raton, Florida.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.